Date published: 2026-4-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

MTCP-1 B1 Inhibitors

Chemical inhibitors of MTCP-1 B1 include a variety of compounds that can impede the protein's function through interference with specific cellular signaling pathways. Phorbol 12-myristate 13-acetate (PMA) can activate protein kinase C (PKC), which in turn leads to phosphorylation and subsequent inhibition of MTCP-1 B1 activity. Staurosporine, a potent PKC inhibitor, can decrease phosphorylation of MTCP-1 B1, which is crucial for its activity, thereby inhibiting its function. Similarly, LY294002 and Wortmannin, as phosphoinositide 3-kinase (PI3K) inhibitors, can reduce the downstream signaling required for MTCP-1 B1 activation and thus inhibit the protein. The PI3K/Akt pathway plays a significant role in the regulation of MTCP-1 B1, and by disrupting this pathway, these inhibitors can suppress MTCP-1 B1 activity.

In parallel, Rapamycin, by inhibiting the mammalian target of rapamycin (mTOR), can have an impact on the signaling pathways that regulate protein synthesis and cell growth, which can lead to a decrease in MTCP-1 B1 activity. Triciribine, an Akt inhibitor, can also diminish the activation of downstream proteins that may include MTCP-1 B1. U0126 and PD98059, as inhibitors of MEK, can prevent the activation of ERK in the MAPK pathway, resulting in decreased activation of proteins regulated by this pathway, including MTCP-1 B1. Additionally, SP600125 and SB203580, which inhibit JNK and p38 MAPK, respectively, can lead to reduced activity of proteins involved in stress response pathways, such as MTCP-1 B1. PP2, an Src family kinase inhibitor, can decrease the phosphorylation and activity of MTCP-1 B1 by inhibiting kinases responsible for phosphorylation events. Lastly, Dasatinib, a broad-spectrum tyrosine kinase inhibitor, can also reduce the phosphorylation and activity of many proteins, including MTCP-1 B1, due to the protein's dependence on phosphorylation for its activity. These chemical inhibitors, by targeting specific kinases and pathways, can effectively inhibit the function of MTCP-1 B1.

Items 1 to 10 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

PMA

16561-29-8sc-3576
sc-3576A
sc-3576B
sc-3576C
sc-3576D
1 mg
5 mg
10 mg
25 mg
100 mg
$41.00
$132.00
$214.00
$500.00
$948.00
119
(6)

PMA is known to activate protein kinase C (PKC), which can lead to phosphorylation and subsequent inhibition of MTCP-1 B1 activity, as PKC-mediated phosphorylation can negatively regulate the activity of certain proteins.

Staurosporine

62996-74-1sc-3510
sc-3510A
sc-3510B
100 µg
1 mg
5 mg
$82.00
$153.00
$396.00
113
(4)

Staurosporine is a potent PKC inhibitor. By inhibiting PKC, it can decrease the phosphorylation of MTCP-1 B1, which is essential for its activity, resulting in functional inhibition of MTCP-1 B1.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

LY294002 is a phosphoinositide 3-kinase (PI3K) inhibitor, and by inhibiting PI3K, it can reduce the downstream signaling required for MTCP-1 B1 activation, leading to its functional inhibition.

Wortmannin

19545-26-7sc-3505
sc-3505A
sc-3505B
1 mg
5 mg
20 mg
$67.00
$223.00
$425.00
97
(3)

Wortmannin is another PI3K inhibitor that can obstruct the PI3K/Akt pathway, leading to decreased activity of MTCP-1 B1 due to the role of this pathway in MTCP-1 B1 regulation.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$63.00
$158.00
$326.00
233
(4)

Rapamycin inhibits the mammalian target of rapamycin (mTOR), which is part of the signaling pathways that regulate protein synthesis and cell growth, potentially leading to decreased activity of MTCP-1 B1.

Triciribine

35943-35-2sc-200661
sc-200661A
1 mg
5 mg
$104.00
$141.00
14
(1)

Triciribine is an Akt inhibitor, and by inhibiting Akt, it can suppress the activation of downstream proteins that may include MTCP-1 B1, leading to its functional inhibition.

U-0126

109511-58-2sc-222395
sc-222395A
1 mg
5 mg
$64.00
$246.00
136
(2)

U0126 is an inhibitor of MEK, which is upstream of ERK in the MAPK pathway; inhibition here can reduce ERK activity and thus decrease activation of proteins regulated by this pathway, including MTCP-1 B1.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$40.00
$92.00
212
(2)

PD98059 is another MEK inhibitor that prevents the activation of ERK, potentially leading to decreased activity of proteins regulated by this pathway, such as MTCP-1 B1.

SP600125

129-56-6sc-200635
sc-200635A
10 mg
50 mg
$40.00
$150.00
257
(3)

SP600125 is an inhibitor of JNK, part of the stress-activated MAPK pathway, and inhibition of JNK can lead to decreased activity of proteins regulated by stress response, including MTCP-1 B1.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$90.00
$349.00
284
(5)

SB203580 is a p38 MAPK inhibitor, and by inhibiting p38 MAPK, it can reduce the activity of proteins that are regulated by this stress-activated pathway, such as MTCP-1 B1.